Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DENSY-MAX
- Development stage
- Unknown
- Lead developer
- Jointcare Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
DENSY-MAX is an oral dietary supplement and bone health formulation developed and marketed by Jointcare Pharmaceuticals. It is a combination product containing calcitriol (0.25 mcg), calcium citrate (1000 mg), magnesium hydroxide (100 mg), and zinc sulphate monohydrate (equivalent to 7.5 mg elemental zinc). Calcitriol, the active form of vitamin D3, facilitates intestinal calcium absorption and regulates bone mineralization by acting as an agonist at the vitamin D receptor. Calcium citrate provides a bioavailable source of elemental calcium necessary for maintaining bone density. Magnesium and zinc serve as essential minerals and enzymatic cofactors involved in bone matrix formation and structural integrity. DENSY-MAX is primarily indicated for the management of weak bone conditions such as osteoporosis and to support recovery from bone fractures.
- Brand names
- DENSY-MAX
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on DENSY-MAX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DENSY-MAX.